Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out if a combination treatment of
perifosine and docetaxel will help shrink or slow the growth of cancer cells in recurrent
ovarian cancer. The safety of this combination treatment will also be studied.